On June 20, 2023, the Suzhou Municipal Bureau of Agriculture and Rural Affairs and the Municipal Animal Disease Prevention and Control Center conducted a "Biosafety Supervision Review" at our company.

Image Name

2023.06.20

To safeguard national security, prevent and address biosecurity risks, protect people's lives and health, conserve biological resources and the ecological environment, promote the healthy development of biotechnology, and foster the building of a community with a shared future for humanity—thereby achieving harmonious coexistence between humans and nature—on June 17, 2022, the Suzhou Municipal Bureau of Agriculture and Rural Affairs conducted "biosecurity preliminary review" activities at Xishan Biotechnology Co., Ltd. The inspection focused on the company’s work in monitoring animal diseases and conducting epidemiological-related testing projects, as well as its research on animal diseases, parasitic infections, and the detection and analysis of pathogenic microorganisms responsible for contagious animal diseases. Additionally, the review examined the company’s efforts in assessing animal immune antibodies.

This "Biosafety Oversight Review" assessed whether our company effectively prevents and responds to threats posed by hazardous biological agents and related factors, providing a comprehensive evaluation from multiple perspectives and demonstrating the reliability and thoroughness of our biosafety practices.

West Mountain

Previous article

November 15, 2022: Yuan Rijin, Chief Veterinary Physician of the Provincial Department of Agriculture and Rural Affairs, Conducts a Research Visit

On May 26, 2023, the Jiangsu Provincial Association of Animal Husbandry and Veterinary Medicine conducted a research survey on the "African Swine Fever" project undertaken by our company.

Next article

Previous article

On May 26, 2023, the Jiangsu Provincial Association of Animal Husbandry and Veterinary Medicine conducted a research survey on the "African Swine Fever" project undertaken by our company.

Next article

On May 26, 2023, the Jiangsu Provincial Association of Animal Husbandry and Veterinary Medicine conducted a research survey on the "African Swine Fever" project undertaken by our company.

More information

On May 10, 2025, our company's Nanoyuan facility successfully completed the filing process for the Suzhou P2 laboratory, becoming one of the first organizations in Suzhou city to receive official accreditation.

On May 10, 2025, our company's Nanoyuan facility successfully completed the filing process for the Suzhou P2 laboratory, becoming one of the first organizations in Suzhou city to receive official accreditation.

[Suzhou, May 10, 2025] Recently, our company’s Nano Park facility successfully completed the filing process for its P2 laboratory with the Suzhou Municipal Bureau of Agriculture and Rural Affairs, officially becoming one of the first animal pathogen microbiology laboratories in the entire Suzhou metropolitan area to receive approval under the newly implemented "Jiangsu Province Animal Pathogen Microbiology Laboratory Filing Management Measures" (effective February 1, 2025).

From September 1 to 2, 2024, our company successfully passed the CMA on-site assessment, further solidifying the authoritative recognition of our capabilities in laboratory animal testing.

From September 1 to 2, 2024, our company successfully passed the CMA on-site assessment, further solidifying the authoritative recognition of our capabilities in laboratory animal testing.

Recently, our company successfully passed the on-site expansion review for CMA accreditation, marking official recognition from a national authority of our professional expertise and robust quality management system in the field of laboratory animal testing. The review took place from September 1 to September 2, 2024, during which the expert panel conducted a comprehensive and rigorous assessment of our laboratory animal testing technologies, equipment, personnel, and management systems—ultimately confirming that we meet the relevant CMA standards.

August 6, 2024: Warmest congratulations to our company on successfully obtaining the veterinary drug production license and the veterinary drug GMP certificate.

August 6, 2024: Warmest congratulations to our company on successfully obtaining the veterinary drug production license and the veterinary drug GMP certificate.

August 6, 2024 – Our company has officially obtained the Veterinary Drug Production License and the Veterinary Drug GMP Certificate issued by the Ministry of Agriculture and Rural Affairs, marking that our company’s quality management system and technical capabilities in the veterinary drug manufacturing sector have met the nation’s stringent high-standard requirements. During this certification process, our immunology-based diagnostic product (Class B) production line successfully passed the on-site GMP inspection for veterinary drugs and was recognized as a qualified production line, laying a solid foundation for the company to further expand into the veterinary diagnostic reagent market.